dichlorotetrakis(dimethyl sulfoxide)ruthenium ii has been researched along with Metastase in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brindell, M; Piotrowska, D; Shoukry, AA; Stochel, G; van Eldik, R | 1 |
| Alessio, E; Bergamo, A; Cocchietto, M; Gava, B; Iengo, E; Sava, G; Sorc, A; Zorzet, S | 1 |
2 other study(ies) available for dichlorotetrakis(dimethyl sulfoxide)ruthenium ii and Metastase
| Article | Year |
|---|---|
Kinetics and mechanism of the reduction of (ImH)[trans-RuCl4(dmso)(Im)] by ascorbic acid in acidic aqueous solution.
Topics: Ascorbic Acid; Electrons; Humans; Hydrogen-Ion Concentration; Imidazoles; Kinetics; Neoplasm Metastasis; Organometallic Compounds; Oxidation-Reduction; Pressure; Solutions; Temperature | 2007 |
Lack of In vitro cytotoxicity, associated to increased G(2)-M cell fraction and inhibition of matrigel invasion, may predict In vivo-selective antimetastasis activity of ruthenium complexes.
Topics: Animals; Antineoplastic Agents; Collagen; Dimethyl Sulfoxide; Drug Combinations; G2 Phase; Humans; Laminin; Mice; Mice, Inbred C57BL; Mitosis; Neoplasm Invasiveness; Neoplasm Metastasis; Organometallic Compounds; Proteoglycans; Ruthenium Compounds; Tumor Cells, Cultured | 2000 |